UAB "GL Pharma Vilnius" Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 1,101,340 |
| 183,557 |
| 16,822 |
| 10,947 |
| 1,825 |
| 100.00 |
| 0.99 |
| 238,968 |
| 84,054 |
| 5,341 |
| 325,685 |
| 2024 |
|---|
| 1,483,931 |
| 251,088 |
| 108,511 |
| 89,761 |
| 15,188 |
| 36.24 |
| 6.05 |
| 328,729 |
| 110,892 |
| 3,109 |
| 431,889 |
| 2025 |
|---|
| 1,580,164 |
| 316,033 |
| 73,293 |
| 58,888 |
| 11,778 |
| 29.21 |
| 3.73 |
| 387,617 |
| 110,891 |
| 2,766 |
| 487,151 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 1,580,164 |
| 316,033 |
| 73,293 |
| 58,888 |
| 11,778 |
| 29.21 |
| 3.73 |
| 387,617 |
| 110,891 |
| 2,766 |
| 487,151 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
1,580,164 €6 % *
Sales per employee (€)
316,033 €26 % *
Profit before tax (€)
73,293 €-32 % *
Net Profit (€)
58,888 €-34 % *
Profit per employee (€)
11,778 €-22 % *
Total profitability (%)
29.21 %-19.40 % *
Net profitability (%)
3.73 %-38.35 % *
Equity (€)
387,617 €18 % *
Amounts Payable And Liabilities (€)
110,891 €0 % *
Non-current Assets (€)
2,766 €-11 % *
CurrentAssets (€)
487,151 €13 % *
